Inflammatory processes linked to major depression and schizophrenic disorders and the effects of polypharmacy in psychiatry: evidence from a longitudinal study of 279 patients under therapy.

European Archives of Psychiatry and Clinical Neuroscience
H H StassenE Seifritz

Abstract

Over the past 2 decades, polypharmacy has become the de-facto standard of acute treatment in psychiatry where patients with psychiatric disorders receive a multiple medication regimen. There is growing evidence for a potential link between major psychiatric disorders and inflammatory processes. Combining these two aspects aims at avoiding polypharmacy attempts among patients with inflammatory activation through alternative treatment strategies. In this study, we addressed the following questions: (1) to what extent can polypharmacy be explained through the factors "diagnosis", "previous history", "severity at baseline", "age", "gender", and "psychiatrist in charge"; (2) what are the differences between polypharmacy and monotherapy regarding efficacy and side effect profiles; and (3) what amount of between-patient variance is explainable by the natural antibody immunoglobulin M (IgM) within each diagnostic group. This naturalistic longitudinal study was comprised of 279 patients under therapy with a clinical diagnosis of depressive (ICD-10: "F3x.x"; n = 195) or schizophrenic disorders (ICD-10: "F2x.x"; n = 84). The study protocol included (1) assessment of previous history by the SADS Syndrome Check List SSCL-16 (lifetime versio...Continue Reading

References

Jul 1, 1978·Archives of General Psychiatry·J Endicott, R L Spitzer
Jan 1, 1987·Schizophrenia Bulletin·S R KayL A Opler
Oct 12, 2000·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·F Holsboer
Feb 1, 1960·Journal of Neurology, Neurosurgery, and Psychiatry·M HAMILTON
Feb 15, 2005·BMC Medical Genetics·Daniel R Hanson, Irving I Gottesman
Jun 14, 2005·Progress in Neuro-psychopharmacology & Biological Psychiatry·Marcus IsingFlorian Holsboer
Aug 5, 2005·Annals of the Rheumatic Diseases·M M J NielenB A C Dijkmans
Sep 15, 2007·The Journal of Clinical Psychiatry·Hans H StassenArmin Szegedi
Apr 27, 2010·Progress in Neurobiology·Richard C Shelton, Andrew H Miller
Jul 10, 2010·Psychotherapy and Psychosomatics·H Edmund PigottJohn J Boren
Sep 21, 2013·The International Journal of Neuropsychopharmacology·H-J MöllerR Grohmann
Feb 22, 2014·Neuroimmunomodulation·Norbert Müller
Oct 13, 2015·British Journal of Pharmacology·L E LaskarisC Pantelis
Jan 16, 2016·Current Neuropharmacology·Frank M SchmidtNicole Lichtblau
Nov 6, 2017·Brain, Behavior, and Immunity·Tina C FranklinRonald S Duman
Jan 13, 2018·International Journal of Psychiatry in Clinical Practice·Ion-George AnghelescuSiegfried Kasper
Oct 3, 2018·Journal of Clinical Psychopharmacology·Cho-Yin HuangLian-Yu Chen
Jan 27, 2019·International Journal of Molecular Sciences·Marcus IsingSusanne Lucae
Jul 2, 2019·Psychological Medicine·Emanuele Felice OsimoGolam M Khandaker
Sep 17, 2019·Journal of Clinical Medicine Research·Daniel J Safer
Jan 11, 2020·World Psychiatry : Official Journal of the World Psychiatric Association (WPA)·Andrew H Miller
Feb 18, 2020·Brain, Behavior, and Immunity·Carmen SchiweckElske Vrieze
Feb 18, 2020·European Archives of Psychiatry and Clinical Neuroscience·Maximilian HuhnStefan Leucht

❮ Previous
Next ❯

Citations

Oct 9, 2020·Journal of Community Psychology·Elizabeth L BuddEmily E Tanner-Smith

❮ Previous
Next ❯

Software Mentioned

EUTwinsS

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Related Papers

Journal of the American Academy of Child and Adolescent Psychiatry
J Markowitz, K Patrick
Canadian Medical Association Journal
MMW Fortschritte der Medizin
Petra A Thürmann
The Australian and New Zealand Journal of Psychiatry
R Khanna
© 2021 Meta ULC. All rights reserved